Jasper Therapeutics Inc.
(JSPR)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | 1.11M | 1.31M | 566.00K | 21.00K | - |
Gross Profit | -1.11M | -1.31M | -566.00K | -21.00K | - |
Operating Income | -68.86M | -51.20M | -36.83M | -20.68M | -4.71M |
Interest Income | 5.20M | - | - | - | 533.00 |
Pretax Income | -66.09M | -37.69M | -30.64M | -31.67M | -4.99M |
Net Income | -64.47M | -24.17M | -23.98M | -31.67M | -4.99M |
Selling & General & Admin | 17.08M | 16.57M | 11.41M | 4.80M | 1.09M |
Research & Development | 51.78M | 34.63M | 25.42M | 15.88M | 3.62M |
Other Expenses | - | 586.00K | -80.00K | -111.00K | - |
Operating Expenses | 68.86M | 51.20M | 36.83M | 20.68M | 4.45M |
Interest Expense | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 68.86M | 51.20M | 36.83M | 20.68M | 4.45M |
Income Tax | -1.63M | -13.51M | -6.65M | -38.45K | -277 |
Shares Outstanding (Basic) | 10.44M | 3.65M | 1.14M | 277.07K | - |
Shares Outstanding (Diluted) | 10.44M | 3.65M | 1.14M | 277.07K | - |
EPS (Basic) | -6.18 | -6.63 | -21.05 | -114.3 | - |
EPS (Diluted) | -6.18 | -6.63 | -21.05 | -114.3 | - |
EBITDA | -64.98M | -38.21M | -31.17M | -31.95M | -277.00K |
Depreciation & Amortization | 1.11M | 1.31M | 566.00K | 21.00K | 4.71M |